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ABSTRACT 
Purpose: Manually tracing regions of interest (ROIs) within 
the liver is the de facto standard method for measuring liver 
attenuation on computed tomography (CT) in diagnosing 
nonalcoholic fatty liver disease (NAFLD). However, manual 
tracing is resource intensive. To address these limitations and 
to expand the availability of a quantitative CT measure of 
hepatic steatosis, we propose the automatic liver attenuation 
ROI-based measurement (ALARM) method for automated 
liver attenuation estimation.  
Methods: The ALARM method consists of two major 
stages: (1) deep convolutional neural network (DCNN)-based 
liver segmentation and (2) automated ROI extraction. First, 
liver segmentation was achieved using our previously 
developed SS-Net. Then, a single central ROI (center-ROI) and 
three circles ROI (periphery-ROI) were computed based on 
liver segmentation and morphological operations. The ALARM 
method is available as an open source Docker container 
(https://github.com/MASILab/ALARM). 
Results: 246 subjects with 738 abdomen CT scans from the 
African American-Diabetes Heart Study (AA-DHS) were used 
for external validation (testing), independent from the training 
and validation cohort (100 clinically acquired CT abdominal 
scans). From the correlation analyses, the proposed ALARM 
method achieved Pearson correlations = 0.94 with manual 
estimation on liver attenuation estimations. When evaluating 
the ALARM method for detection of nonalcoholic fatty liver 
disease (NAFLD) using the traditional cut point of <40 HU, the 
center-ROI achieved substantial agreements (Kappa=0.79) with 
manual estimation, while the periphery-ROI method achieved 
“excellent” agreement (Kappa=0.88) with manual estimation. 
The automated ALARM method had reduced variability 
compared to manual measurements as indicated by a smaller 
standard deviation.  
Conclusions: We propose a fully automated liver attenuation 
estimation method termed ALARM by combining DCNN and 
morphological operations, which achieved “excellent” 
agreement with manual estimation for fatty liver detection. The 
entire pipeline is implemented as a Docker container which 
enables users to achieve liver attenuation estimation in five 
minutes per CT exam. 
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I. INTRODUCTION 
Nonalcoholic fatty liver disease (NAFLD) is the most 
frequent cause of liver disease worldwide and strongly 
associated with diabetes, metabolic syndrome, obesity liver 
failure, liver cancer and cardiovascular disease. (Rinella 2015, 
Angulo 2002)   NAFLD includes a spectrum of conditions from 
isolated hepatic steatosis, inflammation of the liver, liver 
fibrosis and liver failure. NAFLD is the major cause of 
abnormal liver function in the United States and is expected to 
become the major indication for liver transplantation [1, 2]. 
Estimated worldwide prevalence of NAFLD ranges from 6% 
for diagnoses relying upon serum biomarkers of hepatic 
function up to 33% when diagnosed using non-invasive 
imaging techniques such as computed tomography (CT), 
ultrasound or magnetic resonance spectroscopy [3]. Moreover, 
patients with NAFLD are at increased risk of mortality and 
incidence of NAFLD is likely to rise due to its strong 
association with obesity and diabetes [3]. Early identification of 
individuals with NAFLD and nonalcoholic steatohepatitis prior 
to progression to fibrosis and liver failure, is considered critical 
to reducing the negative health consequences. 
 Medical imaging techniques play roles in detecting and 
diagnosing NAFLD in vivo. Computed tomography (CT) of the 
abdomen is a widely used imaging modality for a variety of 
conditions and quantification of hepatic steatosis has been used 
in both  research and clinical practice. [4] Liver attenuation 
from CT is a non-invasive qualitative biomarker allowing 
measurement of liver fat content based on tissue attenuation [5, 
6]. CT attenuation of normal livers typically ranges from 50 to 
75 Hounsfield Units (HU) on non-contrast CT scans, while liver 
attenuation < 40 HU indicates moderate hepatic steatosis, with 
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Fig. 1. The regions of interests (ROIs) of liver attenuation estimations on CT. 
The left panel shows an example of manual ROIs, while the right panel shows
the automatic three circular ROIs (periphery -ROI) proposed in this study. 
a pathologic fat content of  ≥ 30% [7]. CT liver attenuation is 
an accepted biomarker, which has been widely used for 
investigating hepatic steatosis (fatty liver disease) [8, 9], 
coronary artery risk [10, 11], diabetes [12, 13], obesity [14],  
and as tool for gene discovery [8].  
 CT based liver attenuation measurements are traditionally 
performed by a clinically-trained expert with many years’ 
experience in manually tracing the liver ROIs on one or more 
CT slices. In the present study, the expert reader was trained by 
a board-certified radiologist who provides overreads of her 
work. This expert reader has read >1500 liver scans and has 
over 5 years of experience (one slice is presented Figure 1). To 
leverage the robustness of the ROI measurement, multiple ROIs 
are annotated on the CT slice, and the average HU score of each 
ROI from three slices is used to indicate the liver attenuation. 
However, manual tracing is resource and time intensive for 
clinical practitioners, and is not scalable for large-scale medical 
image data. Therefore, it is appealing to develop automatic liver 
 
 
Fig. 2. The liver segmentation stage in ALARM method. Our previously developed convolutional neural network was used to segment liver.  The deep network is 
to convert an input CT slice to a segmentation map, which consists of (1) encoder, (2) large convolutional kernel (LCK) skip connection, and (3) decoder layers.
The PatchGAN is employed as the discriminator to provide additional adversarial loss for training the network with the traditional Dice loss. 
 
 
 
 
Fig. 3. The ROI extraction stage in ALARM method. Two types of automatic ROIs are obtained: (1) a single central ROI (center-ROI) and three circular ROIs 
(periphery-ROI). 
 
attenuation estimation algorithms to alleviate the manual 
efforts.  
Few automatic algorithms have been proposed to achieve the 
liver attenuation estimation on CT [15]. The straight-forward 
strategy is to estimate the liver attenuation from whole liver 
segmentation. However, (1) liver vessels and (2) non-liver 
tissues can be included in the whole liver segmentation, which 
would affect the accuracy of live attenuation estimation. 
Therefore, it is appealing to simulate the manual estimation 
protocols using fully automated image processing. In terms of 
manual estimation, shrinking protocol [15] and peripheral ROI 
protocol [7, 15, 16] are two prevalent protocols. Kullberg et 
al.[15] proposed an automatic liver attenuation estimation 
method to simulate the shrinking protocol, which shrinks the 
liver segmentation within the liver border to avoid non-liver 
tissues. However, the liver vessels are not excluded from this 
protocol, which would lead to higher liver attenuation values 
since the vessels typically have higher HU values. To further 
reduce the affect from vessels, the peripheral ROI protocol [7, 
15, 16] has been widely used in clinical studies by manually 
placing several small ROIs (typically three) in the liver. 
Compare with single ROI, three ROIs capture the heterogeneity 
in the liver better, which enable more robust estimation by 
averaging values from different ROIs. Unfortunately, the fully 
automated peripheral ROI based liver attenuation estimation 
method has not been proposed and evaluated. Moreover, to the 
best of our knowledge, no previous methods have been 
proposed to perform peripheral ROI based liver attenuation 
estimation using deep learning and morphological operations.  
In this manuscript, we propose the Automatic Liver 
Attenuation ROI-based Measurement (ALARM) pipeline, 
which has been developed on 100 CT scans with liver 
segmentation and tested on 738 additional CT scans from 
different populations and CT instruments used in clinical 
practice.  The proposed pipeline simulates the ROI based 
manual liver attenuation labeling protocol by obtaining three 
liver ROIs on a non-contrast CT scan. Briefly, our previously 
proposed deep convolutional neural network (DCNN) based 
abdominal organ segmentation method [17] was employed to 
segment the liver. Next, the morphological operations were 
included to identify an ROI in the center of the liver (center-
ROI) and set of three circular ROIs in the periphery of the liver 
(periphery-ROI) upon the liver segmentation. The entire 
ALARM pipeline has been implemented as a Docker container 
[18], which enables the users to achieve the automatic liver 
attenuation estimations from an abdominal CT scan by using 
one line of command. The ALARM pipeline can be 
downloaded from (https://github.com/MASILab/ALARM). To 
our knowledge, the proposed ALARM pipeline is the first open-
source work that performs automatic ROI-based liver 
attenuation estimation by combining deep convolutional neural 
network (DCNN) and morphological operations.  
II. METHODS 
The end-to-end framework of the proposed ALARM pipeline 
is presented in Figure 2 and 3. The ALARM pipeline consists 
of two sections: liver segmentation and morphological 
operations. The liver segmentation was implemented using 
deep convolutional neural network described in our previous 
work [17]. 
A. Manual Liver Attenuation Estimation Protocol 
The manual liver attenuation ROIs are traced by clinical 
experts, on abdominal CT scans with slice thickness of 2.5 mm 
and 50 field of view (FOV) (“Scan Series 1” in Figure 4). Then, 
a single axial view at central liver location is selected by the 
annotator. Next, three circles (each ~ 100 mm2) are placed over 
the peripheral are of the right lobe of the liver (shown in Figure 
1). The slice selection and circle drawing rely on the 
annotator’s experience in clinical practice, analysts were 
instructed to avoid vessels, hepatic pathology and artifacts 
when feasible. 
B. Whole Liver Segmentation using Deep Convolutional 
Neural Network 
The first step in the ALARM pipeline is to obtain whole liver 
segmentation. The previously proposed SS-Net [17] deep 
convolutional neural network was employed to achieve whole 
liver segmentation (Figure 2). This network was originally 
designed for spleen MRI segmentation and was adapted to CT 
liver segmentation in this work. Briefly, the SS-Net is a 2D 
abdominal organ segmentation network consisting of both a 
generator and discriminator (Figure 2). The generator is to 
convert an input CT slice to a segmentation map, which consists 
of (1) encoder, (2) skip connection, and (3) decoder layers. The 
encoder consists of residual blocks (in green), which are 
employed from the canonical residual network (ResNet) [19], 
while the skip connection (in orange) and decoder (in purple 
and blue) are employed from the global convolutional network 
(GCN) [20]. The PatchGAN [21] is used as the discriminator to 
provide additional adversarial loss for training the generator. 
The SS-Net is trained by axial view images from 3D scans. 
However, the clinically acquired DICOM images are not 
always axial acquisition (e.g., axial, coronal, and sagittal). 
Therefore, to be compatible with different acquisitions, we first 
perform DICOM to NIFTI conversion to reconstruct the 3D 
volumes. Then, each axial slice in a 3D CT volume was resized 
to 256×256 image for both training and testing purposes. The 
details of preprocessing and training have previously been 
reported [17]. Briefly, learning rate = 0.00001, optimization 
method = Adam, loss function = Dice loss and Adversarial loss, 
and batch size = 32.  After deep segmentation, the output 
256×256 two-dimensional axial view segmentations were 
resampled to the original axial image resolution using nearest 
neighbor interpolation. Then, the 2D slices were stacked to 3D 
segmentation volumes in the original image space. 
C. Central Liver Measurement (center-ROI) 
Due to the limitation of the segmentation accuracy, the 
segmentation could be over-segmented or under-segmented at 
the boundaries of liver tissue (Figure 4b). Therefore, it would 
be inaccurate to get liver attenuation directly from the whole 
liver segmentation. To address this issue, we performed 
morphological erosion on liver segmentation to ensure the 
eroded segmentation is located within the liver. We proposed 
the first type of automatic liver attenuation ROI in the central 
region, termed center-ROI, which is an eroded segmentation 
based on the whole liver segmentation. The process of creating 
the center-ROI is shown in Figure 3, where a series of 
morphological erosion operations were conducted upon the 
whole liver segmentations. Briefly, we first resample the 3D 
liver binary segmentation to 1mm isotropic volume, and 
perform 3D erosion morphological operations until the 
remaining volume size <= 1000 mm3. The threshold 1000 mm3 
is empirically chosen as an order of magnitude less than the 
standard liver size. The 3×3×3 kernel of erosion is a 3D 
“diamond” shape, where indices [1,1,0] [0,1,1] [1,0,1] [1,1,1] 
[1,2,1] [2,1,1] [1,1,2] are set to one while the remaining are set 
to zero. Then, the 3D region within the center liver ROI is 
defined as center-ROI, and the corresponding liver attenuation 
is calculated by the mean HU score within the center-ROI. 
D. Peripheral Liver ROI Measurement (periphery -ROI) 
The center-ROI reflects the mean HU scores within the 
central liver. The central region of the liver includes the large 
vascular structures, specifically the portal and hepatic veins 
which would not be representative of hepatic fat content. Next, 
we perform additional operations beyond the center-ROI. The 
new method extracts periphery-ROI, replicating the manual 
process and thus avoiding the major vascular structures located 
in the central portion of the liver.  
Since the manual ROIs are annotated on a 2D central axial 
slice in liver, we simulate that procedure using automated 
pipeline. Briefly, we continue performing morphological 
erosion operations on center-ROI until the volume size equals 
to 0. The smallest ROI from the previous non-zero volume 
iteration was used to locate the central point. Then, the central 
point 𝑝𝑐 = [𝑥𝑐, 𝑦𝑐, 𝑧𝑐]  is defined as the coordinate of the 
centroid of the small 3D volume, in which  𝑧𝑐  indicates the 
index of central axial slice to measure the periphery-ROI. From 
𝑝𝑐 , we draw three lines on posterior, lateral, and anterior 
direction to get the 𝑝𝑏1, 𝑝𝑏2, and 𝑝𝑏3 at the boundary of liver 
segmentation. 𝑝𝑏1 = [𝑥𝑐, 𝑦1, 𝑧𝑐], 𝑝𝑏2 = ൣ𝑥2, 𝑦𝑐, 𝑧𝑐൧, and 𝑝𝑏3 =
[𝑥𝑐, 𝑦𝑐, 𝑧3]. Next, we define the proportional coefficient 𝛼 to 
obtain the three periphery-ROI center locations 𝑝1, 𝑝2, and 𝑝3, 
whole coordinates are calculated by 
𝑝1 = [𝑥𝑐, 𝑦𝑐 − (𝑦𝑐 − 𝑦1)𝛼, 𝑧𝑐] 
𝑝2 = ൣ𝑥𝑐 − (𝑥𝑐 − 𝑥1)(1 − 𝛼), 𝑦𝑐, 𝑧𝑐൧ 
𝑝3 = [𝑥𝑐, 𝑦𝑐 + (𝑦3 − 𝑦𝑐)(1 − 𝛼), 𝑧𝑐] 
(1) 
For all the experiences in this study, the coefficients were 
empirically set as 𝛼 = 1/3 to (1) be tolerant to the imperfect 
liver segmentation, and (2) not be too close to the center point 
𝑝𝑐 . The ablation study of the proportional coefficient 𝛼  is 
provided in Figure S2 in supplementary materials. Using 𝑝1, 𝑝2, 
and 𝑝3 as centers, three circles of periphery-ROI are obtained, 
whose radius is empirically set to 7mm (area ≈150 mm2). The 
mean HU score with each periphery-ROI is defined as liver 
attenuation score. 
E. ALARM Docker 
The ALARM method consists of a variety of image 
processing algorithms (e.g., image preprocessing, deep 
segmentation, ROI extraction, and visualization). It would be 
time and resource intensive to deploy for users who lack a 
background in programming. Therefore, we integrated all steps 
in a single Docker container [18] as an “end-to-end” solution, 
called “ALARM Docker”. The inputs of the Docker are 
DICOM format images from a single abdomen CT scan. The 
outputs of the ALARM Docker are the liver attenuation ROIs 
and measurements. As a result, the ALARM method can be 
deployed on abdominal CT scans using only one line of 
command. The ALARM Docker and example data from [22] is 
available at (https://github.com/MASILab/ALARM) with the 
details in the Supplementary Materials. 
III.  EXPERIMENTS 
A. Data 
One hundred clinically-acquired abdominal CT scans [22] 
with manual liver segmentation were used as training and 
validation data, while another independent cohort with 246 
subjects from the African American-Diabetes Heart Study (AA-
DHS) [23, 24] were used as external validation (testing) data.  
For each of the 246 AA-DHS study participants included in the 
external validation (testing), three abdomen series were 
acquired each differing only in slice thickness or FOV as shown 
in Figure 5. This cohort is only used in testing and independent 
to the training since it is excluded from training or tuning the 
deep learning parameters. 
The 100 training and validation CT abdominal scans with 
liver segmentations were acquired during portal venous contrast 
phase with volume size 512 × 512 × 33 to 512 × 512 × 158. 
The in-plane resolution varies from 0.54 × 0.54 mmଶ  to 
0.98 × 0.98 mmଶ , while the slice thickness ranges from 1.5 
mm to 7.0 mm (details can be found in [22]).For AA-DHS scans 
[23, 24], each subject has three different scan series (Figure 5). 
In scan series 1, the field of view (FOV) is 50 mm while the 
slice thickness is 2.5 mm. In scan series 2, the FOV is 35 mm 
while the slice thickness is 2.5 mm. In scan series 3, the FOV is 
35 mm while the slice thickness is 1.25 mm. For three scan 
series, the in-plane size is 512 × 512. The manual annotations 
were performed on scan series 1. 
B. Experimental Design 
For the liver segmentation using the method in § section 2.2, 
75 abdomen CT scans were randomly picked as training while 
the remaining 25 were used as internal validation. The 738 AA-
DHS scans were not used in the training and validation; 
therefore, the parameters were only tuned on 100 training and 
validation cohort. After obtaining the whole liver 
segmentations, the center-ROI and periphery-ROI are 
computed based on the ALARM pipeline. The entire ALARM 
pipeline was deployed on all 738 AA-DHS scans, which took 
~5 minutes for each scan using a typical workstation with Intel 
Xeon ES-2630 V4 2.2 GHz CPU, 32G memory, and NVIDIA 
Titan GPU (12 GB memory) and CUDA 8.0. 
    
 
Fig. 4. Qualitative visualizations of raw abdomen CT scan, liver segmentation, center-ROI and periphery-ROI from ALARM pipeline (a) shows the results of three 
subjects from accurate liver segmentation, while (b) presents the results of three subjects with the inaccurate liver segmentation. The first row indicates the raw
input CT scan. The second row shows the liver segmentation from the deep learning segmentation. The third row shows the central-ROI, while the fourth row 
shows the periphery-ROI. The ROI based liver attenuation method is able to tolerate imperfect whole liver segmentation after performing morphological operations.
 
 
Fig. 5 Qualitative visualizations of raw abdomen CT scan, liver segmentation, center-ROI and periphery-ROI from ALARM pipeline. The left panel shows the 
results for one subject from three scanning protocols 1 to 3. The right panel presents the results for another subject from three scanning protocols. The first row 
indicates the raw input CT scan. The second row shows the liver segmentation from the deep learning segmentation. The third row shows the central-ROI, while 
the fourth row shows the periphery-ROI. The ROI based liver attenuation method is able to deployed on different imaging protocols. 
IV.  STATISTICAL ANALYSES 
Summary measures including means, standard deviations 
(SD), medians, ranges, and other measures of distribution were 
used to assess performance of center-ROI and periphery-ROI 
and manual methods. Also presented are scatterplots and 
Pearson correlation coefficients that show relationships within 
methods and between methods across the range of liver values 
encountered. We also present Bland-Altman plot assessing the 
limits of agreement for our final model comparing the mean of 
three ROIs measured by the periphery-ROI and manual 
methods [25]. As liver attenuation values <40 HU are considered 
indicative of moderate to severe steatosis, we also evaluated the 
methods on the basis of number of mean attenuations falling 
below or at or above the 40 HU threshold [6, 26, 27]. Predictive 
agreement for identifying <40 HU was tested using kappa (K) 
and 95% confidence intervals (95% CI) [28, 29] and suggested 
scales for assessing agreement are presented 22. All analyses 
were performed using STATA 15.1 (StataCorp LLC, College 
Station, TX, USA) and Bland-Altman and scatterplots were 
craested using GraphPad Prism 6.05 (GraphPad Software, Inc., 
LaJolla, CA. USA).  
V. RESULTS 
Figures 4 and 5 present the qualitative results from the 
ALARM pipeline. Figure 4 shows the segmentation and ROI 
results of six subjects. The center-ROI and periphery-ROI 
results for the three subjects in the left panel are generated when 
the liver segmentations are accurate. The center-ROI and 
periphery-ROI results for the three subjects in the right panel 
are achieved when the liver segmentations are inaccurate. 
Results demonstrate that the proposed method is able to identify 
well placed periphery-ROI even when the liver segmentation is 
not accurate. Figure 5 shows the segmentation and ROI results 
of two subjects. For each subject, the liver segmentation, 
center-ROI, and periphery-ROI results are presented for the 
three different scan series. Note that the manual liver 
segmentation results are not shown in Figure 4 and 5 since those 
patients are from AA-DHS testing cohort, in which we do not 
have manual liver segmentation results.  
A. Segmentation Performance 
The liver segmentation performance of the SS-Net is 
evaluated on 25 internal validation abdominal CT scans with 
manual liver annotation. The segmentation performance with 
median DSC values of SS-Net on the 100 epochs is provided in 
Figure S1 in the Supplementary Materials. From the validation 
results, the segmentation model with epoch=85 is chosen for the 
remaining morphological operations, which achieves median 
DSC = 0.942, mean DSC = 0.934, standard deviation = 0.021 
on 25 internal validation cohorts. 
B. Correlations of Manual ROI and Periphery-ROI 
Three ROIs are identified for both manual ROI delineation 
and periphery-ROI extractions. Figure 6 shows the Pearson 
correlation of liver attenuation estimation across three ROIs. 
The upper panel shows the cross ROI correlations for manual 
 
 
Fig. 6. The upper panel shows the scatter plots as well as the Pearson correlation between three manual ROIs, while the lower panel shows the results between three 
circular ROIs in periphery-POI. The blue dots indicate the Hounsfield Unit (HU), and the red lines are the linear regression results. 
 
delineation, while the lower panel shows the cross ROI 
correlations for periphery-ROI estimations. From the results, 
the correlations between manual ROIs are higher than 
periphery-ROIs. 
Then, one-to-one ROI wise correlations between each 
manual ROI and periphery-ROI is presented in Figure 7. From 
Figure 6 and 7, The periphery-ROI has larger inter-ROI 
variations. Therefore, to reduce the variations for automatic 
liver attenuation estimation, the mean HU scores across three 
ROIs for both manual and automatic methods is used in this 
study, whose Bland-Altman plot [25] are shown in Figure 8. 
The left panel in Figure 8 shows that we achieve Pearson 
correlation = 0.94 between mean periphery-ROI and mean 
manual ROI for liver attenuation estimation. The right panel in 
Figure 8 presents the Bland-Altman plot with 95% confidence 
interval. The x-axis indicates the average of mean periphery-
ROI and mean manual ROI, while the y-axis indicates the 
differences by subtracting mean periphery-ROI from mean 
manual ROI. The upper and lower dash lines indicate the 95% 
confidence interval (6.916 and -6.938), while the middle dash 
line shows the bias (-0.011).  
C. Quantitative Results on Fatty Liver Detection 
The quantitative results have been presented in Table 1 and 
2. Table 1 shows the HU scores along with mean, SD and range 
for center-ROI and periphery-ROI across three scan series (1-
3) measured by ALARM method as well as HU scores for series 
1 by manual method are provided in Table 1. The row “HU<40” 
in Table 1 indicates the estimation number of subjects with fatty 
liver based on Hounsfield units (HU<40). On the same scan 
series 1, 16 subjects were detected with fatty liver using center-
ROI, while 17 subjects were detected with fatty liver using 
periphery-ROI. Using manual measurement, 19 subjects were 
identified with fatty liver. Agreement between automatic and 
manual measurements are evaluated using the K statistic [28]. 
The K statistic on inter-rater agreement between manual and the 
proposed ALARM methods on fatty liver detection (HU<40) 
are presented in Table 2. The K values are all > 0.7, which 
indicate substantial agreement between manual and the 
ALARM methods. The fatty liver  detection based on the 
periphery-ROI ALARM method  agreement with manual 
estimation (K = 0.88, p<0.0001) is considered to be “almost 
perfect” [30]. When applying ALARM method on different 
series (Series 2 and 3), the center-ROI achieved K = 0.82 and 
 
 
Fig. 7. The correlation maps between each manual ROI and each periphery-ROI. The blue dots indicate the Hounsfield Unit (HU), and the red lines are the linear
regression results. 
 
 
 
Fig. 8. The left panel shows the correlations between mean periphery-ROI and mean manual ROI. The blue dots indicate the Hounsfield Unit (HU), and the red 
lines are the linear regression results. The right panel shows the Bland-Altman plot between mean periphery-ROI vs. mean manual ROI. The gray area indicates 
the 95% confidence interval. 
0.84 with manual detection for Series 2 and 3. The periphery-
ROI achieved K = 0.91 and 0.72 with manual detection for 
Series 2 and 3. The sensitivity and specificity results of the 
detection performance are provided in Table 2 as well. 
VI. DISCUSSION 
In the present study, we evaluated the use of the ALARM 
method for automated measurement of liver attenuation and 
prevalence of NAFLD, an important marker of future 
cardiovascular risk. To the best of our knowledge, the proposed 
ALARM pipeline is the first open-source pipeline that performs 
automatic ROI-based liver attenuation estimation by combining 
DCNN and morphological operations. ALARM method 
determination of liver attenuation and NAFLD detection was 
highly correlated with gold-standard manual tracings 
performed by a trained analyst. From Figure 5 and Table 1, the 
proposed ALARM method is able to achieve good automatic 
liver attenuation estimation across different scan series. The 
manual protocols of liver attenuation estimation can be done 
efficiently in clinical practice. However, it might not be a 
scalable method and typically not desired in large-scale 
imaging analysis studies, especially for the large-scale 
retrospective studies. Using the proposed ALARM method, we 
are able to achieve the liver attenuation measurements from the 
large-scale cohorts automatically. 
The prevalence of NAFLD, which may already affect up to 
33% worldwide, may be expected to only increase in the 
coming years secondary to the obesity epidemic. NAFLD is 
associated with higher risk for cardiovascular disease risk and 
progression of NAFLD to more serious liver disease increases 
risk of hepatic cancer, liver failure and the need for liver 
transplantation.  It is thus imperative that large scale means for 
identifying those at risk for NAFLD be developed. CT is often 
used for population studies of liver attenuation and NAFLD, but 
these studies are limited by the resource-intensive need to train 
analysts to manually place liver ROIs consistently. 
Nevertheless, liver attenuation has been measured thousands of 
study participants in Framingham [31], Jackson Heart Study 
[32], CARDIA [33] and MESA [34] and pooled to provide 
evidence of the genetic components of NAFLD [8]. Thus, we 
developed and tested the ALARM method for liver attenuation 
determination potentially opening the door for measurement of 
fatty liver in tens of thousands of study participants or patients.  
Using the proposed method, the resource consuming manual 
annotation is eliminated from the pipeline. Moreover, the 
ALARM method typically takes five minutes to perform liver 
attenuation estimation from a abdomen CT scan.  Therefore, we 
are able to deploy the ALARM method on the larger scale 
clinical cohorts without manual efforts to understand the 
relationship between liver attenuation and diseases. From the 
results, the proposed method achieved “excellent” agreement 
with manual measurement on the fatty liver detection. 
The present study has some limitations. One limitation of the 
proposed ALARM method is that the whole pipeline has not 
been implemented in a single “end-to-end” deep convolutional 
neural network. The deep convolutional neural network was 
only employed for liver segmentation, but not for the ROI 
extraction. In the future, the improvement could be to 
implement a single end-to-end deep network to perform multi-
task learning on liver segmentation and ROI detection 
simultaneously [35]. Although performance was excellent, it 
could even be enhanced by training a landmark detection 
DCNN directly using labeled ROIs on >1000 subjects.  
Another limitation of the proposed ALARM method is that 
the liver vessels were not explicitly considered when extracting 
the ROIs in automatic methods. Although the periphery-ROI 
TABLE I 
THE LIVER ATTENUATION MEASUREMENTS OF CENTER-ROI AND MEAN PERIPHERY-ROI FOR DIFFERENT SEQUENCE PROTOCOL 
 center-ROI periphery-ROI Manual
 Series 1 Series 2 Series 3 Series 1 Series 2 Series 3 Series 1 
Mean, HU 56.6 56.7 56.9 55.9 56.7 56.9 55.9
SD, HU 9.3 9.3 9.2 9.4 9.3 9.2 10.4
Median, HU 58.5 58.6 58.6 57.8 58.6 58.6 58.0
Minimum, HU 7.2 8.7 8.5 6.2 8.7 8.5 4.3 
Maximum, HU 88.9 89.9 97.7 84.3 89.9 97.7 94.9 
25 percent, HU 53.9 54.1 54.2 52.4 54.1 54.2 52.3 
75 percent HU 62.5 62.3 62.5 61.6 62.3 62.5 62.5
HU<40, n(%) 16 (6.4%) 17 (6.8%) 14 (5.6%) 17 (6.8%) 16 (6.4%) 19 (7.5%) 19 (7.5%)
* Scan Series 1: 2.5 mm, 50 FOV; Scan Series 2: 2.5 mm, 35 FOV; Scan Series 3: 1.25 mm, 35 FOV 
 
TABLE II 
AGREEMENT OF CENTER-ROI AND PERIPHERY-ROI WITH MANUAL METHOD FOR DETECTION OF LIVER ATTENUATION <40 HU 
 ALARM center-ROI vs. Manual ALARM periphery-ROI vs. Manual 
 Series 1 Series 2 Series 3 Series 1 Series 2 Series 3
Κappa 0.79 0.82 0.84 0.88 0.91 0.72 
95% CI 0.63 – 0.94 0.68 – 0.96 0.70 – 0.98 0.77 – 0.99 0.81 – 0.99 0.55 – 0.88
p < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Agreement 97.2% 97.6% 98.0% 98.4% 98.8% 96.0% 
Sensitivity 73.7% 79.0% 73.7% 84.2% 84.2% 73.7% 
Specificity 99.1% 99.2% 100.0% 99.6% 100.0% 97.9% 
* Kappa agreement ranges: 0.21-0.40, fair; 0.41-60, moderate; 0.61-0.80, substantial; >081, almost perfect based on Landis and Koch (1977). 
 
method has been designed to mimic the ROI placement used in 
most manual methods and thus reduces the effects of liver 
vessels, the ROIs could still contain vessels. As a result, liver 
attenuation estimation could be affected since the HU scores are 
different between vessels and liver tissues and the periphery-
ROI does not guarantee the elimination of the non-liver tissues 
(i.e. veins and arteries). In the future, the automated liver 
attenuation estimation methods would achieve comparable or 
even better performance compared with manual protocols if the 
non-liver tissues segmentation is introduced into the pipeline to 
avoid the non-liver tissue in ROI extraction.  
Moreover, the present test of the ALARM method was 
performed in a community-based study using careful research 
protocols for CT acquisition and, as such, we cannot directly 
extrapolate its use to clinically-obtained scans and other 
populations including those with clinically-significant liver 
disease. The peripheral ROI is designed as 2D measurements to 
simulate the manual ROI protocol. In clinical scenarios, a single 
overlay image with automated 2D ROIs can be visualized for 
efficient quality assurance (QA), which would require fewer 
human efforts for completed QA the results of 3D ROIs slice-
by-slice. 
The 246 AA-DHS testing scans are independent to the 100 
clinical acquired training and validation scans to ensure the fair 
external validation. Therefore, the manually traced circles and 
slice numbers are not included in developing the method. As a 
result, the slice location of the peripheral ROIs can be different 
from the slice location of the manual ROIs, and we do not force 
such consistency. The ALARM method is proposed to simulate 
both shrinking protocol (center-ROI) and peripheral ROI 
protocol (periphery-ROI) in a single fully automated pipeline. 
Since the periphery-ROI is achieved based on the center-ROI, 
the failure of center-ROI might lead to the failure of periphery-
ROI (although this did not happen in the present study).  
ALARM method Moderate inaccuracy in whole liver 
segmentation (Figure 4) is tolerable and will still permit 
accurate center-ROI and periphery-ROI placements. However, 
the global failure of liver segmentation (not encountered in this 
study) might lead to the global failures of center-ROI and 
periphery-ROI. Using different segmentation methods (SS-Net 
and U-Net), the proposed ALARM framework achieves 
consistent and comparable liver attenuation performance 
(Figure S3, Table S1 and S2). The results demonstrate that the 
strategies for center-ROI and periphery-ROI are tolerant to 
moderately inaccurate whole liver segmentation in different 
scenarios (SS-Net and U-Net). Details are provided in the 
Supplementary Materials. 
The aim of this study is to develop an automatic liver 
attenuation estimation method simulating human estimation 
protocols, by combining deep learning segmentation and 
morphological operations. In this study, SS-Net is employed as 
the deep learning segmentation method in the ALARM method, 
without claiming the SS-Net is an optimal solution. We have 
shown that the ALARM method is an open framework that 
allows users to adapt different segmentation approaches (i.e., 
the U-Net [36] in Supplementary Materials). Details of the 
quantitative performance comparing ALARM-U (U-Net) with 
ALARM (SS-Net) are provided in Supplementary Materials. 
Other deep learning methods might have resulted in more 
favorable results but are outside the scope of this work.  
VII. CONCLUSION 
In this paper, a fully automated liver attenuation 
measurement method is proposed. This method computes liver 
attenuation in five minutes by incorporating deep learning and 
morphological operations. Liver attenuation measured using 
the ALARM method was highly correlated with attenuation 
measured manually by a clinically trained, highly experienced 
analyst. Moreover, when compared to the gold-standard manual 
method for detection of NAFLD based on the attenuation cut 
point of 40 HU, the proposed ALARM method produced 
“excellent” agreement (K = 0.88) with manual measurement. 
The present study suggests the ALARM method may be used 
to reliably measure liver attenuation and assess NAFLD 
prevalence in large epidemiologic studies and scan repositories 
potentially including tens of thousands of participants. 
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SUPPLEMENTARY MATERIALS 
A. Alarm Docker 
Docker (https://www.docker.com) is a containerized 
technique that provides an open-source and lightweight solution 
to deploy developed algorithms on any operating system (OS). 
Compared with virtual machines, Docker containers use 
smaller and neater capsule upon OS rather than employing 
hypervisors, which emulates the virtual hardware. As the GPU 
based computing was used in the ALARM method, the GPU 
extension version of Docker, NVIDIA-Docker 
(https://github.com/NVIDIA/nvidia-docker), was used as the 
containerized implementation. 
 The Docker was established on Ubuntu 16.04 with CUDA 
8.0, MATLAB 2016a, Python 2.7, and PyTorch 0.2. The 
Docker has been made publicly available in our Dockerhub 
(https://hub.docker.com/u/masidocker), which can be deployed 
to local computer by calling the following command (provided 
with Ubuntu bash as example): 
sudo docker pull 
masidocker/spiders:liver_attenuation_v1_0_1 
Once the docker has been imported to the local computer, 
users are able to obtain the final output files by running a single 
command: 
sudo nvidia-docker run -it --rm -v {input path}:/INPUTS/ -v 
{output path}:/OUTPUTS 
masidocker/spiders:liver_attenuation_v1_0_1 
/extra/run_deep_wholebody.sh 
B. Ablation Study 
The quantitative performance of training (75 CT scans) and 
validation (25 CT scans) using the SS-Net is provided in the 
Figure S1. In ALARM method, the default value of the 
proportional coefficient 𝛼  is 1/3. The ablation test of 𝛼 =
ቂଵ଺ ,
ଵ
ଷ ,
ଵ
ଶ ,
ଶ
ଷ ,
ହ
଺ቃ is provided in Figure S2.  
C. Quantitative Results 
The quantitative results of replacing SS-Net with U-Net in 
ALARM (called “ALARM-U”) are provided in the 
supplementary materials. The training data and training hyper-
parameters to train SS-Net are kept same for training U-Net, 
except the batch size = 16 for U-Net due to the memory 
limitation. The mean HU scores across three peripheral ROIs 
for both manual and automatic ALARM-U methods are used in 
this study and the e scatterplot and Bland-Altman plot are 
shown in Figure S3. The left panel in Figure S3 shows the high 
correlation (r=0.95) between mean periphery-ROI and mean 
manual ROI for liver attenuation estimation. The right panel 
presents the Bland-Altman plot with 95% confidence interval. 
The x-axis indicates the average of mean periphery-ROI and 
mean manual ROI, while the y-axis indicates the differences by 
subtracting mean periphery-ROI from mean manual ROI. The 
detailed quantitative results of ALARM-U have been presented 
in Tables S1 and S2. 
D. Compare ALARM and ALARM-U 
Figure S3 shows the correlations between mean periphery-
ROI and mean manual ROI for the ALARM-U method. 
Compared with the ALARM in Figure 9, the ALARM-U 
achieves slightly higher correlation. However, the ALARM-U 
yields larger difference (y-axial) range in the Bland-Altman 
plot compared with ALARM method. Table S1 and S2 for 
ALARM-U present the same comparisons shown for ALARM 
in Tables 1 and 2. The ALARM method achieves better Kappa 
scores in terms of periphery-ROI on series 1. However, 
generally comparable liver attenuation estimation 
performances are achieved by employing heterogeneous deep 
learning segmentation methods in the ALARM pipeline. 
 
 
Fig. S1. Liver segmentation performance with median Dice similarity 
coefficient (DSC) of SS-Net across 100 training epochs is provided in the blue 
curve. The corresponding performance for training is provided in the red curve
 
 
Fig. S2. The ablation study of the proportional coefficient α in fatty liver 
detection using series 1 scans. The green bars indicate the number of detected
fatty liver cases among 246 patients in AADHS study. The red dash line shows
19 cases are detected from manual protocol. From the results, the default value
α=1/3 has the closest estimation. The α=1/6 (closer to boarder) detects more 
false positive cases since the HU scores are lower when the ROIs cover the
areas outside the liver boarder. 
 
 
 
TABLE I 
 
Fig. S3. The left panel shows the correlations between mean periphery-ROI and mean manual ROI. The blue dots indicate the Hounsfield Unit (HU), and the red
lines are the linear regression results. The right panel shows the Bland-Altman plot between mean periphery-ROI vs. mean manual ROI. The gray area indicates 
the 95% confidence interval. 
 
TABLE SI 
THE LIVER ATTENUATION MEASUREMENTS OF CENTER-ROI AND MEAN PERIPHERY-ROI FOR DIFFERENT SEQUENCE PROTOCOL 
 ALARM-U center-ROI ALARM-U periphery-ROI Manual
 Series 1 Series 2 Series 3 Series 1 Series 2 Series 3 Series 1
Mean, HU 57.2 57.2 57.2 56.0 55.9 56.1 55.9
SD, HU 9.2 9.6 9.1 9.4 9.6 9.5 10.4 
Median, HU 58.9 58.8 59.0 58.3 57.9 58.1 58.0 
Minimum, HU 8.6 10.1 9.2 7.6 4.2 8.4 4.3
Maximum, HU 89.7 118.4 92.0 72.8 106.9 79.7 94.9
25 percent, HU 54.2 54.3 54.3 52.7 52.7 52.6 52.3
75 percent HU 63.0 62.8 63.0 62.1 61.9 62.7 62.5 
HU<40, n(%) 16 (6.3%) 15 (5.9%) 15 (5.9%) 17 (6.6%) 18 (7.1%) 15 (5.9%) 19 (7.5%) 
* Scan Series 1: 2.5 mm, 50 FOV; Scan Series 2: 2.5 mm, 35 FOV; Scan Series 3: 1.25 mm, 35 FOV 
 
TABLE SII 
AGREEMENT OF CENTER-ROI AND PERIPHERY-ROI WITH MANUAL METHOD FOR DETECTION OF LIVER ATTENUATION <40 HU  
 ALARM-U center-ROI vs. Manual ALARM-U periphery-ROI vs. Manual
 Series 1 Series 2 Series 3 Series 1 Series 2 Series 3
Κappa 0.81 0.77 0.84 0.85 0.88 0.75 
95% CI 0.66 – 0.96 0.61 – 0.94 0.70 – 0.98 0.72 – 0.98 0.77 – 0.99 0.58 – 0.92
p < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Agreement 97.7% 97.2% 98.0% 98.0% 98.4% 96.9% 
Sensitivity 73.7% 68.4% 73.7% 79.0% 84.2% 68.4% 
Specificity 99.6% 99.6% 100.0% 99.6% 99.6% 99.2% 
* Κappa agreement ranges: 0.21-0.40, fair; 0.41-60, moderate; 0.61-0.80, substantial; >081, almost perfect based on Landis and Koch (1977). 
 
 
 
